Literature DB >> 12931190

Generation of prion transmission barriers by mutational control of amyloid conformations.

Peter Chien1, Angela H DePace, Sean R Collins, Jonathan S Weissman.   

Abstract

Self-propagating beta-sheet-rich protein aggregates are implicated in a wide range of protein-misfolding phenomena, including amyloid diseases and prion-based inheritance. Two properties have emerged as common features of amyloids. Amyloid formation is ubiquitous: many unrelated proteins form such aggregates and even a single polypeptide can misfold into multiple forms--a process that is thought to underlie prion strain variation. Despite this promiscuity, amyloid propagation can be highly sequence specific: amyloid fibres often fail to catalyse the aggregation of other amyloidogenic proteins. In prions, this specificity leads to barriers that limit transmission between species. Using the yeast prion [PSI+], we show in vitro that point mutations in Sup35p, the protein determinant of [PSI+], alter the range of 'infectious' conformations, which in turn changes amyloid seeding specificity. We generate a new transmission barrier in vivo by using these mutations to specifically disfavour subsets of prion strains. The ability of mutations to alter the conformations of amyloid states without preventing amyloid formation altogether provides a general mechanism for the generation of prion transmission barriers and may help to explain how mutations alter toxicity in conformational diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931190     DOI: 10.1038/nature01894

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

1.  Observation of sequence specificity in the seeding of protein amyloid fibrils.

Authors:  Mark R H Krebs; Ludmilla A Morozova-Roche; Katie Daniel; Carol V Robinson; Christopher M Dobson
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

2.  Insulin forms amyloid in a strain-dependent manner: an FT-IR spectroscopic study.

Authors:  Wojciech Dzwolak; Vytautas Smirnovas; Ralf Jansen; Roland Winter
Journal:  Protein Sci       Date:  2004-05-28       Impact factor: 6.725

3.  Structure of the β2-α2 loop and interspecies prion transmission.

Authors:  Cyrus Bett; Natalia Fernández-Borges; Timothy D Kurt; Melanie Lucero; K Peter R Nilsson; Joaquín Castilla; Christina J Sigurdson
Journal:  FASEB J       Date:  2012-04-09       Impact factor: 5.191

4.  Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid.

Authors:  Bon W Koo; Andrew D Miranker
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

5.  Structural insights into a yeast prion illuminate nucleation and strain diversity.

Authors:  Rajaraman Krishnan; Susan L Lindquist
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways.

Authors:  Ali Reza A Ladiwala; Jonathan S Dordick; Peter M Tessier
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

7.  Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions.

Authors:  Jijun Dong; Jesse D Bloom; Vladimir Goncharov; Madhuri Chattopadhyay; Glenn L Millhauser; David G Lynn; Thomas Scheibel; Susan Lindquist
Journal:  J Biol Chem       Date:  2007-09-24       Impact factor: 5.157

8.  Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+].

Authors:  Peter M Tessier; Susan Lindquist
Journal:  Nat Struct Mol Biol       Date:  2009-06       Impact factor: 15.369

9.  Fibrinogen has chaperone-like activity.

Authors:  Huadong Tang; Yan Fu; Yujie Cui; Yingbo He; Xing Zeng; Victoria A Ploplis; Francis J Castellino; Yongzhang Luo
Journal:  Biochem Biophys Res Commun       Date:  2008-12-04       Impact factor: 3.575

Review 10.  Curli provide the template for understanding controlled amyloid propagation.

Authors:  Xuan Wang; Matthew R Chapman
Journal:  Prion       Date:  2008-04-05       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.